Featured Publications
Mechanisms and Clinical Features of Co-Occurring Opioid and Nicotine Use
Lichenstein SD, Zakiniaeiz Y, Yip SW, Garrison KA. Mechanisms and Clinical Features of Co-Occurring Opioid and Nicotine Use. Current Addiction Reports 2019, 6: 114-125. PMID: 32864292, PMCID: PMC7451029, DOI: 10.1007/s40429-019-00245-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNicotine useClinical featuresCholinergic systemUse disordersOpioid use disorderPurpose of ReviewToSubstance use disordersSex/gender considerationsRecent FindingsOpioidPathophysiological mechanismsSmoking cessationRisk factorsTreatment outcomesDrug rewardOpioidsFurther studiesHigh rateTreatmentDisordersHighlight areasPainReviewToEtiologyPharmacologicalCessationSex Differences across Retrospective Transitions in Posttraumatic Stress and Substance Use Disorders
Peltier MR, Roberts W, Verplaetse TL, Zakiniaeiz Y, Burke C, Moore KE, McKee SA. Sex Differences across Retrospective Transitions in Posttraumatic Stress and Substance Use Disorders. Journal Of Dual Diagnosis 2021, 18: 11-20. PMID: 34965199, PMCID: PMC9086923, DOI: 10.1080/15504263.2021.2016027.Peer-Reviewed Original ResearchConceptsDrug use disordersOngoing posttraumatic stress disorderSubstance use disordersSUD/PTSDPosttraumatic stress disorderNew PTSD diagnosisImpact of sexUse disordersDiagnosis of SUDPast-year substance use disorderPTSD diagnosisConcurrent substance use disordersDiagnosis of PTSDPoor treatment outcomesNational Epidemiologic SurveyBidirectional relationshipSex-specific analysesPotential sex-specific differencesTreatment outcomes
2023
Psychometric properties of the Persian version of the cognitive emotion regulation questionnaire-short (CERQ-P-short): Reliability, validity, factor structure, treatment sensitivity, and measurement invariance
Hasani J, Emadi Chashmi S, Zakiniaeiz Y, Potenza M. Psychometric properties of the Persian version of the cognitive emotion regulation questionnaire-short (CERQ-P-short): Reliability, validity, factor structure, treatment sensitivity, and measurement invariance. Journal Of Psychiatric Research 2023, 170: 1-10. PMID: 38096672, PMCID: PMC11131131, DOI: 10.1016/j.jpsychires.2023.11.011.Peer-Reviewed Original ResearchObsessive-compulsive disorderMeasurement invarianceGeneralized anxietyEmotion regulationSubstance use disordersMaladaptive cognitive emotion regulation strategiesCognitive emotion regulation strategiesCognitive Emotion Regulation QuestionnaireDiscriminant validityFactor structureTreatment sensitivityCognitive emotion regulationEmotion regulation strategiesEmotion Regulation QuestionnairePsychometric propertiesDepression Anxiety Stress Scale-21Anxiety Stress Scale-21Good measurement invarianceStress Scale-21Test-retest coefficientsCERQScale-21Fit indicesAdult psychiatric patientsAlpha coefficientExamining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III
Fields L, Roberts W, Schwing I, McCoy M, Verplaetse T, Peltier M, Carretta R, Zakiniaeiz Y, Rosenheck R, McKee S. Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III. Drug And Alcohol Dependence Reports 2023, 7: 100162. PMID: 37159814, PMCID: PMC10163607, DOI: 10.1016/j.dadr.2023.100162.Peer-Reviewed Original ResearchTobacco use disorderSubstance use disordersBody mass indexUse disordersPsychiatric conditionsRisk of SUDAdditional substance use disordersSingle health conditionsRelated Conditions Wave IIIWorse health outcomesNational Epidemiological SurveyPsychiatric disorder diagnosisHarmful substance useDSM-5 criteriaConcurrent obesityComorbid obesityMass indexSUD diagnosisRisk factorsObesityComorbid diagnosesEpidemiological surveyHealth outcomesNESARC-IIIDisorder diagnosis
2020
Chapter 9 Sex and the dopaminergic system: Insights from addiction studies
Woodcock EA, Zakiniaeiz Y, Morris ED, Cosgrove KP. Chapter 9 Sex and the dopaminergic system: Insights from addiction studies. Handbook Of Clinical Neurology 2020, 175: 141-165. PMID: 33008522, PMCID: PMC11267480, DOI: 10.1016/b978-0-444-64123-6.00011-4.Peer-Reviewed Original ResearchConceptsDopaminergic systemSex differencesSubstance use disordersDopamine neurobiologyTobacco smokingSex hormonesPsychiatric disordersUse disordersDopamine functionClinical disparitiesCognitive functionDisordersAddiction researchAddiction studiesNeurobiologySmokingDifferencesGenetic underpinningsHormone